Company:  XBIOTECH INC. (XBIT)
Form Type:  SC TO-I
Filing Date:  1/14/2020 
CIK:  0001626878 
Address:  8201 E. RIVERSIDE DRIVE
BUILDING 4, SUITE 100
 
City, State, Zip:  AUSTIN, Texas 78744 
Telephone:  512-386-2930 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$11.49  
Change: 
0.55 (5.03%)  
Trade Time: 
Apr 03  
Market Cap: 
$331.52M
Trade XBIT now with

© 2020  
Description of Business
XBiotech Inc. ("XBiotech" or the "Company) is a biopharmaceutical company that discovers and develops True Human(TM) monoclonal antibodies for treating a variety of diseases. True Human(TM) monoclonal antibodies are derived from those which occur naturally in human beings--as opposed to being derived from animal immunization or otherwise engineered. XBiotech's belief is that naturally occurring monoclonal antibodies have the potential to be safer, more effective and faster to develop than their non-naturally occurring counterparts. XBiotech is developing a pipeline of product candidates targeting both inflammatory and infectious diseases and has developed commercial scale manufacturing technology and infrastructure that reduces the cost and time to launch new product candidates. The Company has fully integrated development capabilities at its headquarters in Austin, Texas including non-clinical and clinical operations and manufacturing.
Register and access this filing in:     
  FORM SC TO-I
  EXHIBIT 99.(A)(1)(I)
  EXHIBIT 99.(A)(1)(II)
  EXHIBIT 99.(A)(1)(III)
  EXHIBIT 99.(A)(1)(IV)
  EXHIBIT 99.(A)(1)(V)
  EXHIBIT 99.(A)(5)(I)
  EXHIBIT 99.(A)(5)(II)